| Gilead Sciences, Inc. |
Non-Executive |
Arcus Biosciences, Inc. (RCUS)
|
2025-02-18 |
$11.00 |
0.0% |
1,363,636
|
$14,999,996 |
| Gilead Sciences, Inc. |
Non-Executive |
ASSEMBLY BIOSCIENCES, INC. (ASMB)
|
2024-12-19 |
$21.37 |
0.0% |
940,499
|
$20,098,464 |
| Gilead Sciences, Inc. |
Non-Executive |
Xilio Therapeutics, Inc. (XLO)
|
2024-12-18 |
$1.04 |
0.0% |
1,759,978
|
$1,830,377 |
| Gilead Sciences, Inc. |
Non-Executive |
Xilio Therapeutics, Inc. (XLO)
|
2024-04-02 |
$0.76 |
1.7% |
485,250
|
$368,790 |
| Gilead Sciences, Inc. |
Non-Executive |
Kyverna Therapeutics, Inc. (KYTX)
|
2024-02-12 |
$22.00 |
-65.5% |
910,000
|
$20,020,000 |
| Gilead Sciences, Inc. |
Non-Executive |
Arcus Biosciences, Inc. (RCUS)
|
2023-06-28 |
$19.26 |
-16.1% |
1,010,000
|
$19,452,600 |
| Gilead Sciences, Inc. |
Non-Executive |
Allovir, Inc. (ALVR)
|
2023-06-27 |
$86.25 |
-99.1% |
127,429
|
$10,990,762 |
| Gilead Sciences Inc |
Non-Executive |
Arcus Biosciences, Inc. (RCUS)
|
2021-01-31 |
$39.00 |
-58.6% |
5,650,000
|
$220,350,000 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
-50.7% |
$-156,253,133 |
$308,110,989 |